Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

Background Endocrine therapy is the most important treatment modality of breast cancer patients whose tumors express the estrogen receptor α (ERα). The androgen receptor (AR) is also expressed in the vast majority (80–90%) of ERα-positive tumors. AR-targeting drugs are not used in clinical practice,...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research : BCR Vol. 26; no. 1; pp. 111 - 14
Main Authors: Gao, Huanyao, Wei, Lixuan, Indulkar, Shreya, Nguyen, Thanh Thanh. L., Liu, Duan, Ho, Ming-Fen, Zhang, Cheng, Li, Hu, Weinshilboum, Richard M., Ingle, James N., Wang, Liewei
Format: Journal Article
Language:English
Published: London BioMed Central 04.07.2024
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1465-542X, 1465-5411, 1465-542X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first